State of the 3D Cell Culture Field and Drug Discovery
Five years ago, the field of 3D cell culture was primarily an academic pursuit with graduate students and post [...]
Barriers to Adopting Machine Learning and Digital Pathology in the Clinic
As a leading provider of digital pathology services and solutions, we have worked with dozens of pharmaceutical companies in [...]
Blog Post: Pre-clinical Ophthalmology Services
Visikol is a contract research organization that provides researchers at academic institutions and pharmaceutical companies with unique services in [...]
Cell Viability Assays for 3D Cell Culture
One of the most common assays used with in vitro models is an assessment of total ATP which is [...]
Applying Deep Learning to Bio-Imaging and Digital Pathology
Bioimaging is the subfield of biology that focuses primarily on capturing images or video of biological processes, commonly at [...]
Targeting Fibrosis
Fibrosis is the pathological overaccumulation of excess connective tissue as a result of imbalances during the body’s healing processes [...]
2D and 3D Cell Culture Assay for Cytotoxicity Testing
In evaluating potential therapeutic candidates, it is crucial to understand early on in the discovery process if the candidates [...]
An Overview of Multiplex Slide Imaging Approaches
Mike Johnson2020-12-29T14:40:46-05:00At Visikol, our core objective is to help service Clients and product Customers to transform their tissues into quantitative [...]
Using Multiplex Imaging and Digital Pathology for IO Therapeutics
Mike Johnson2019-10-02T19:32:57-05:00Over the last few years, the development of immuno-oncology therapeutics has been on the rise with many leading pharmaceutical [...]
Four New Visikol HISTO Publications!
At Visikol, we are dedicated to not only providing our Clients with best-in-class drug discovery services but also continuing [...]